No categories found

Home >

Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.

Monday, 6th of August 2018 Print

Chesson HW, Meites E, Ekwueme DU, Saraiya M, Markowitz LE.

Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.

Vaccine. 2018 Jul 5;36(29):4362-4368. doi: 10.1016/j.vaccine.2018.04.071.

https://www.sciencedirect.com/science/article/pii/S0264410X18305784?via%3Dihub

(C) All Rights Reserved - Child Survival.net